FDA Approves First Treatment for Nonradiographic Axial Spondyloarthritis - Rheumatology Advisor

FDA Approves First Treatment for Nonradiographic Axial Spondyloarthritis  Rheumatology Advisor

The Food and Drug Administration (FDA) has approved Cimzia (certolizumab pegol; UCB) injection for the treatment of adults with nonradiographic axial ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases